Literature DB >> 33707578

Modelling of HIV prevention and treatment progress in five South African metropolitan districts.

Cari van Schalkwyk1, Rob E Dorrington2, Thapelo Seatlhodi3,4, Claudia Velasquez5, Ali Feizzadeh5, Leigh F Johnson3.   

Abstract

Globally, large proportions of HIV-positive populations live in cities. The Fast-Track cities project aims to advance progress toward elimination of HIV as a public health threat by accelerating the response in cities across the world. This study applies a well-established HIV transmission model to provide key HIV estimates for the five largest metropolitan districts in South Africa (SA): Cape Town, Ekurhuleni, eThekwini, Johannesburg and Tshwane. We calibrate the model to metro-specific data sources and estimate progress toward the 90-90-90 targets set by UNAIDS (90% of people living with HIV (PLHIV) diagnosed, 90% of those diagnosed on antiretroviral therapy (ART) and viral suppression in 90% of those on ART). We use the model to predict progress towards similarly defined 95-95-95 targets in 2030. In SA, 90.5% of PLHIV were diagnosed in 2018, with metro estimates ranging from 86% in Johannesburg to 92% in eThekwini. However, only 68.4% of HIV-diagnosed individuals nationally were on ART in 2018, with the proportion ranging from 56% in Tshwane to 73% in eThekwini. Fractions of ART users who were virally suppressed ranged from 77% in Ekurhuleni to 91% in eThekwini, compared to 86% in the whole country. All five metros are making good progress to reach diagnosis targets and all (with the exception of Ekurhuleni) are expected to reach viral suppression targets in 2020. However, the metros and South Africa face severe challenges in reaching the 90% ART treatment target.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33707578      PMCID: PMC7952913          DOI: 10.1038/s41598-021-85154-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  32 in total

1.  Optima: A Model for HIV Epidemic Analysis, Program Prioritization, and Resource Optimization.

Authors:  Cliff C Kerr; Robyn M Stuart; Richard T Gray; Andrew J Shattock; Nicole Fraser-Hurt; Clemens Benedikt; Markus Haacker; Maxim Berdnikov; Ahmed Mohamed Mahmood; Seham Abdalla Jaber; Marelize Gorgens; David P Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2015-07-01       Impact factor: 3.731

2.  HIV risk and prevention among men who have sex with men in rural South Africa.

Authors:  Kabelo Maleke; Nosipho Makhakhe; Remco Ph Peters; Geoffrey Jobson; Glenn De Swardt; Joseph Daniels; Timothy Lane; James A McIntyre; John Imrie; Helen Struthers
Journal:  Afr J AIDS Res       Date:  2017-03       Impact factor: 1.300

3.  Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial.

Authors:  Niklaus D Labhardt; Isaac Ringera; Thabo I Lejone; Thomas Klimkait; Josephine Muhairwe; Alain Amstutz; Tracy R Glass
Journal:  JAMA       Date:  2018-03-20       Impact factor: 56.272

4.  Ending the HIV epidemic in the USA: an economic modelling study in six cities.

Authors:  Bohdan Nosyk; Xiao Zang; Emanuel Krebs; Benjamin Enns; Jeong E Min; Czarina N Behrends; Carlos Del Rio; Julia C Dombrowski; Daniel J Feaster; Matthew Golden; Brandon D L Marshall; Shruti H Mehta; Lisa R Metsch; Ankur Pandya; Bruce R Schackman; Steven Shoptaw; Steffanie A Strathdee
Journal:  Lancet HIV       Date:  2020-03-05       Impact factor: 12.767

5.  Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study.

Authors:  Kate K Orroth; Esther E Freeman; Roel Bakker; Anne Buvé; Judith R Glynn; Marie-Claude Boily; Richard G White; J Dik F Habbema; Richard J Hayes
Journal:  Sex Transm Infect       Date:  2007-04-03       Impact factor: 3.519

6.  Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa.

Authors:  Leigh F Johnson; Rob E Dorrington; Haroon Moolla
Journal:  South Afr J HIV Med       Date:  2017-07-27       Impact factor: 2.744

Review 7.  Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis.

Authors:  Steve Kanters; Marco Vitoria; Meg Doherty; Maria Eugenia Socias; Nathan Ford; Jamie I Forrest; Evan Popoff; Nick Bansback; Sabin Nsanzimana; Kristian Thorlund; Edward J Mills
Journal:  Lancet HIV       Date:  2016-09-06       Impact factor: 12.767

8.  Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study.

Authors:  Jessica B McGillen; Sarah-Jane Anderson; Mark R Dybul; Timothy B Hallett
Journal:  Lancet HIV       Date:  2016-08-03       Impact factor: 12.767

9.  The effectiveness and cost-effectiveness of community-based support for adolescents receiving antiretroviral treatment: an operational research study in South Africa.

Authors:  Geoffrey Fatti; Debra Jackson; Ameena E Goga; Najma Shaikh; Brian Eley; Jean B Nachega; Ashraf Grimwood
Journal:  J Int AIDS Soc       Date:  2018-02       Impact factor: 5.396

10.  Estimating and projecting the number of new HIV diagnoses and incidence in Spectrum's case surveillance and vital registration tool.

Authors:  Severin G Mahiane; Kimberly Marsh; Robert Glaubius; Jeffrey W Eaton
Journal:  AIDS       Date:  2019-12-15       Impact factor: 4.177

View more
  5 in total

1.  Predicting the HIV/AIDS epidemic and measuring the effect of AIDS Conquering Project in Guangxi Zhuang Autonomous Region.

Authors:  Shizhao Ma; Yi Chen; Xiulan Lai; Guanghua Lan; Yuhua Ruan; Zhiyong Shen; Qiuying Zhu; Shuai Tang
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

2.  SAHCS 2021 Conference Summary.

Authors:  David C Spencer
Journal:  South Afr J HIV Med       Date:  2022-04-14       Impact factor: 1.835

3.  Geographical variation in HIV testing in South Africa: Evidence from the 2017 national household HIV survey.

Authors:  Sean Jooste; Musawenkosi Mabaso; Myra Taylor; Alicia North; Yolande Shean; Leickness C Simbayi; Tarylee Reddy; Leonard Mwandingi; Tenielle Schmidt; Portia Nevhungoni; Samuel Manda; Khangelani Zuma
Journal:  South Afr J HIV Med       Date:  2021-08-31       Impact factor: 2.744

4.  Cytomegalovirus retinitis and antiretroviral treatment: A fifteen year experience.

Authors:  Serisha Jay Narain; Linda Visser; Wilbert Sibanda
Journal:  South Afr J HIV Med       Date:  2022-03-08       Impact factor: 2.744

5.  Predictors of low antiretroviral adherence at an urban South African clinic: A mixed-methods study.

Authors:  Connor P Bondarchuk; Nwabisa Mlandu; Tasneem Adams; Elma de Vries
Journal:  South Afr J HIV Med       Date:  2022-02-10       Impact factor: 2.744

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.